Literature DB >> 9824319

Comparison of seven quantitative assays to assess lymphocyte cell death during HIV infection: measurement of induced apoptosis in anti-Fas-treated Jurkat cells and spontaneous apoptosis in peripheral blood mononuclear cells from children infected with HIV.

T W McCloskey1, S Chavan, S M Lakshmi Tamma, S Pahwa.   

Abstract

The study of apoptosis in relation to various human disease states, particularly HIV infection, has seen a tremendous increase in activity. In this article, values obtained by seven different assays, designed to quantify apoptosis and applicable to the study of HIV infection, are compared in two cell systems: (1) stimulus-induced apoptosis in Jurkat cells treated with anti-Fas antibody and (2) spontaneous apoptosis in PBMCs isolated from HIV-infected children. The methods used included measurement of cells with subdiploid DNA content, labeling of DNA strand breaks by the TUNEL reaction, annexin V surface labeling for the detection of exposed phosphatidylserine, cytoplasmic antigen labeling with the apoptosis-specific antibody Apo 2.7, detection of changes in flow cytometric light-scattering properties, trypan blue dye exclusion by light microscopy, and detection of changes in cellular chromatin by fluorescence microscopy. These methods produced well-correlated values in the Jurkat system, whereas the same set of methods produced more discrepant values in the PBMC analyses, especially in those patients with low CD4 counts. Specifically, our results showed that the trypan blue test was unacceptable for quantification of apoptosis during HIV infection, whereas TUNEL, of all the methods tested, showed excellent overall correlation in both cell systems, was highly specific, and matched microscopic observation of the cells. Although many of the methods were suited to the study of a homogeneous cell line, caution must be exercised when examining cell death in a heterogeneous cell mixture from an HIV-infected individual.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9824319     DOI: 10.1089/aid.1998.14.1413

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  6 in total

1.  Effects of therapy with highly active anti-retroviral therapy (HAART) and IL-2 on CD4+ and CD8+ lymphocyte apoptosis in HIV+ patients.

Authors:  L Caggiari; S Zanussi; M T Bortolin; M D'andrea; G Nasti; C Simonelli; U Tirelli; P De Paoli
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

2.  Quantifying corneal endothelial cell death.

Authors:  J G Crowston; P R Healey; A Maloof; B Allan
Journal:  Br J Ophthalmol       Date:  2002-09       Impact factor: 4.638

3.  Apoptosis of activated CD4+ and CD8+ T cells is enhanced by co-culture with hepatocytes expressing hepatitis C virus (HCV) structural proteins through FasL induction.

Authors:  Khadija Iken; Lin Huang; Hewan Bekele; Emmett V Schmidt; Margaret James Koziel
Journal:  Virology       Date:  2005-12-05       Impact factor: 3.616

4.  Comparative analysis of different apoptosis detection methods in human testicular cancer.

Authors:  Hans Ulrich Schmelz; Michael Abend; Matthias Port; Michael Schwerer; Ekkehard W Hauck; Wolfgang Weidner; Christoph Sparwasser
Journal:  Urol Res       Date:  2004-04-29

5.  Hsp70 localizes differently from chaperone Hsc70 in mouse mesoangioblasts under physiological growth conditions.

Authors:  Giuseppina Turturici; Fabiana Geraci; Maria Elena Candela; Giovanni Giudice; Fidelina Gonzalez; Gabriella Sconzo
Journal:  J Mol Histol       Date:  2008-10-08       Impact factor: 2.611

6.  Oxidative stress preconditioning of mouse perivascular myogenic progenitors selects a subpopulation of cells with a distinct survival advantage in vitro and in vivo.

Authors:  Cesare Gargioli; Giuseppina Turturici; Maria M Barreca; Walter Spinello; Claudia Fuoco; Stefano Testa; Salvatore Feo; Stefano M Cannata; Giulio Cossu; Gabriella Sconzo; Fabiana Geraci
Journal:  Cell Death Dis       Date:  2018-01-03       Impact factor: 8.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.